Impact of Sampling Window Variability on Pharmacokinetic Parameters Estimated by Non‐Compartmental Analysis: Case Studies of Various Types of Drugs

Documenti analoghi

• Phase 1 Mass Balance Study of Pizuglanstat: An Investigational Hematopoietic Prostaglandin D Synthase Inhibitor
  di: Ryuzo Hanada, et al.
  Pubblicazione: (2025)
• Impact of Sotorasib, a KRAS G12C Inhibitor, on the Pharmacokinetics and Therapeutic Window of Digoxin, a P‐Glycoprotein Substrate
  di: Panli Cardona, et al.
  Pubblicazione: (2025)
• Lack of Pharmacokinetic Drug–Drug Interactions Between Bepirovirsen and Nucleos(t)ide Analogs
  di: Kelong Han, et al.
  Pubblicazione: (2025)
• A Phase 1 Study to Evaluate the Pharmacokinetic Drug‐Drug Interaction Between Islatravir and Methadone in Participants on Stable Methadone Therapy
  di: Randolph P. Matthews, et al.
  Pubblicazione: (2024)
• Physiologically Based Pharmacokinetic Absorption Model for Pexidartinib to Evaluate the Impact of Meal Contents and Intake Timing on Drug Exposure
  di: Shintaro Nakayama, et al.
  Pubblicazione: (2024)